281 related articles for article (PubMed ID: 9726037)
21. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
Yamada N; Miyamoto M; Isogaya M; Suzuki M; Ikezawa S; Ohno M; Otake A; Umemura K
J Thromb Haemost; 2003 Aug; 1(8):1813-9. PubMed ID: 12911598
[TBL] [Abstract][Full Text] [Related]
22. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
[TBL] [Abstract][Full Text] [Related]
23. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
24. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
[TBL] [Abstract][Full Text] [Related]
25. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Theis JG; Dellweg H; Perzborn E; Gross R
Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
[TBL] [Abstract][Full Text] [Related]
26. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
27. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
28. Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin.
Li R; Fries S; Li X; Grosser T; Diamond SL
Clin Chem; 2013 Aug; 59(8):1195-204. PubMed ID: 23592503
[TBL] [Abstract][Full Text] [Related]
29. The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions.
Nagai H; Takeda H; Yamaguchi S; Tanaka H; Matsuo A; Inagaki N
Prostaglandins; 1995 Aug; 50(2):75-87. PubMed ID: 8588075
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
31. Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.
Rolin S; Dogné JM; Michaux C; Delarge J; Masereel B
Prostaglandins Leukot Essent Fatty Acids; 2001 Aug; 65(2):67-72. PubMed ID: 11545621
[TBL] [Abstract][Full Text] [Related]
32. Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.
Kojok K; Mohsen M; El Kadiry AEH; Mourad W; Merhi Y
J Am Heart Assoc; 2020 Feb; 9(3):e013396. PubMed ID: 32009527
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
Kariyazono H; Nakamura K; Arima J; Ayukawa O; Onimaru S; Masuda H; Iguro Y; Majima HJ; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):157-67. PubMed ID: 15091003
[TBL] [Abstract][Full Text] [Related]
34. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809
[TBL] [Abstract][Full Text] [Related]
35. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
Vargaftig B; Joseph D; Hatmi M
Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684
[TBL] [Abstract][Full Text] [Related]
36. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activity of 2-(6-carboxyhexyl)-3-n-hexylcyclohexylamine (IBI P-05006), a thromboxane receptor antagonist.
Rotondo S; De Gaetano G; Cerletti C
Eur J Pharmacol; 1993 Feb; 232(1):41-5. PubMed ID: 8384563
[TBL] [Abstract][Full Text] [Related]
38. Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid.
Minuz P; Lechi C; Tommasoli R; Gaino S; Degan M; Zuliani V; Bonapace S; Benoni G; Adami A; Cuzzolin L
Thromb Res; 1995 Dec; 80(5):367-76. PubMed ID: 8588198
[TBL] [Abstract][Full Text] [Related]
39. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
Tubaro E; Belogi L; Mezzadri CM
Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
